07 Jan 2001

Nucleo cmp - España

Updated: 07 Jan 2001

Nucleo cmp "forte" 30 capsulas

Neuralgias (lumbago, ciática, otalgias, etc), neuritis (herpes zoster, parálisis facial, polineuritis, recuperación de hemipléjicos, poliomielíticos, etc).

Nucleo cmp Description, Presentation and Dosage

Nucleo cmp Description

Nucleo cmp Drug Class Description

Complejo b, otras asociaciones

Nucleo cmp Drug Description


Nucleo cmp Presentation

Nucleo cmp Presentation

Vía im ("Forte"):. - Adultos: 1 inyectable cada 24 h. - Niños: medio inyectable cada 24 h o 1 inyectable cada 48-72 h. Vía oral ("Normal" y "forte"):. - Adultos: 1 cápsula 3 veces al día. - Niños: 1 cápsula 2 veces al día.

Nucleo cmp Manufacturer


Related Learning Zones

Anti-Coagulation Video Channel

Anti-Coagulation Video Channel

The Anti-Coagulation Video Channel is regularly updated with expert videos discussing how to prevent stroke and systemic embolism in non-valvular atrial fibrillation (AF) patients and how to prevent and treat venous thromboembolism (VTE). This free resource is intended for primary care practitioners and specialists involved in the treatment and follow up care of patients with AF or VTE.

This resource has been developed in collaboration with Boehringer Ingelheim.



The COPD Knowledge Centre has been designed to provide healthcare professionals with free access to educational materials and disease awareness information. This includes information on the epidemiology, pathophysiology and symptoms of COPD and the latest guidelines for the diagnosis, treatment and management of the disease.

COPD-specific resources such as videosguidelinesinfographics, materials for your patients, upcoming events, useful websites and symposium videos and materials from ATS 2014 and ATS 2015 are available free of charge.

Nucleo cmp Dosage

Nucleo cmp Precautions, Reactions and Contraindications

Nucleo cmp Special Precautions

Related Drugs - Gastroenterologia

Back to top